Prestige Biologics'
CDEMO Service
Provides Best Solution for Biomanufacturing
NEWS
- [Press Release]Prestige Biologics attends BioProcess International 2022
- [Press Release]Prestige Biologics participated in BIOPLUS-INTERPHEX KOREA 2022
- [Press Release]Prestige Biologics Advancing as Global CDMO in Line with Korean Government's Bio-health Industry Innovation Plan
- [Presentation]Biopharmaceutical Manufacturing from Clinical to Commercial Stage by Single Use System
- [Press Release]Prestige Biologics wins Best CDMO Award at the Korea Bioprocessing Excellence Awards 2022
- [Announcement]Prestige Biologics acquired ‘GDP’ (Good Distribution Practice) certification
SERVICES
Prestige Biologics can provide a bright future by enabling customer's molecule to influence the world.
-
Overview
Overview
As a Biopharmaceutical CDEMO, we provide services such as customized
more
global research/development, engineering, manufacturing, and regulatory support. -
Development
Development
We provide fast and reasonable development capabilities through independent process
more
development from cell lines development to formulation development. -
Engineering
Engineering
From the process development stage, we provide optimal engineering
more
consulting and design by joining the engineering team. -
Manufacturing
Manufacturing
Korea's first full single-use system and unique ALITA Smart BioFactory
more
provide fast and secure production services.
